MindWalk Holdings Corp.
NCM: HYFTLive Quote
About MindWalk Holdings Corp.
Healthcare
Biotechnology
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
📊 Fundamental Analysis
MindWalk Holdings Corp. demonstrates a profit margin of -43.6%, which is below the sector average, suggesting competitive pressure.
The company recently reported 52.4% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -58.8%, which indicates that capital utilization is currently under pressure.
At a current price of $1.07, HYFT currently sits at the 24th percentile of its 52-week range (Range: $0.40 - $3.25).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$77.54M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
0.64
52W High
$3.25
52W Low
$0.40
Avg Volume
423K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App